About
Endotronix, Inc. is a medical technology company focused on digital health solutions for managing heart failure. Founded by cardiothoracic surgeon Anthony Nunez, MD, and mechanical engineer Harry D. Rowland, PhD, the company develops innovative platforms that promote proactive, patient-centered care for individuals with advanced heart failure. The flagship product, the Cordella™ Heart Failure System, is an integrated disease management platform that enhances patient outcomes and reduces hospital readmissions. It collects and securely transmits biometric and clinical data to heart failure clinicians, providing ongoing insights into patient health. The system includes the myCordella™ Patient Management Portal, which aids clinicians in managing complex chronic care. For patients needing intensive monitoring, the Cordella™ Pulmonary Artery (PA) Sensor offers a wireless, implantable solution that delivers advanced hemodynamic data. Endotronix aims to shift heart failure treatment from reactive to proactive management, improving patients' quality of life while alleviating pressure on healthcare systems. The company has received recognition as one of the "Fierce 15" MedTech companies in 2017, underscoring its role as an innovator in heart failure care.
Technologies
Keywords
Company Information
-
Employees 110
-
Founded 2007
-
Annual Revenue $64300000
-
Total Funding $193535363
Location
1415 W Diehl Rd, Naperville, Illinois, United States, 60563-1102
